Preimplantation genetic diagnosis (PGD) is performed on IVF generated Blastomeres, totipotent cells of human embryo.
Each daughter cell formed by the division of fertilized ovum contains exactly the same genetic information as the "parent" cell, and has the same genetic potential to further divide.
Blastomere biopsy is prerequisite of PGD.
It is performed on a 3 days old IVF embryo.
A 3 days old embryo is made of 8 cells, known as blastomere.
1-2 blastomeres are gently separated from rest of the embryo and pipetted out of the covering shell, zona pellucidia, for genetic screening.
All the 8 cell are expected to be identical in a 3 days old embryo. Therefore, it doesn't matter which of the eight blastomeres are removed for genetic screening.
However, studies show that IVF generated embryos present almost 50 percent chances of mosaicism, where chromosome representation of blastomeres differ.
To minimize erroneous genetic screening results, PGD is performed on 2 cells of 8 celled embryo.
Does biopsy for preimplantation genetic diagnosis affect fetal development?
Possible flaws in preimplantation genetic diagnosis (PGD)
For related pages of interest please see the right column of the page.
Back To
Genetics in Fetal Development
Liked what you read just now? Pay it forward!
Chrmosome and Genes
Modes of Gene Expression
Meiosis and Mitosis
Monozygotic Twins
Modes of Gene Expression
Incidence
Genetic Mutations
Single Gene Disorders
Multifactorial Disorders
Chromosomal Disorders
Prenatal Screening
Types of Genetic Screening
Indications
Quadruple Screen Test
Alpha-Fetoprotein
Amniocentesis
Chorionic villus sampling
Preimplantation genetic diagnosis
Blastomere Biopsy
Risk of Mosaicism: Why?
Possible Flaws in Diagnosis
Vectors Used
Principle in safety
Germline modification therapy
Somatic cells gene therapy
Cons of Gene therapy
Embryonic and Adult Stem Cells
Application of Stem Cells
Liked What You Just Read?
Pay It Forward!
New! Comments
Have your say about what you just read! Leave me a comment in the box below.